Valsartan/hydrochlorothiazide

Valsartan/hydrochlorothiazide
Combination of
Valsartan	Angiotensin II receptor antagonist
Hydrochlorothiazide	Thiazide diuretic
Clinical data
Trade names	co-vasotec
AHFS/Drugs.com	FDA Professional Drug Information
MedlinePlus	a611032
License data	US FDA: Valsartan+hydrochlorothiazide
Pregnancy category	US: D (Evidence of risk)
Routes of administration	Oral
ATC code	C09DA03 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
PubChem (CID)	9810581
KEGG	D09197^Y
(verify)

Valsartan/hydrochlorothiazide (INNs, trade name Co-vasotec) is an antihypertensive drug combination of an angiotensin II receptor antagonist with hydrochlorothiazide,^[1] the most common diuretic to be combined with other blood pressure lowering substances.

References

Antihypertensives: agents acting on the renin–angiotensin system (C09)

ACE inhibitors ("-pril")	Sulfhydryl-containing: Captopril Rentiapril Zofenopril Dicarboxylate-containing: Enalapril^# Benazepril Cilazapril Delapril Imidapril Lisinopril (+HCT) Moexipril Perindopril (+indapamide) Quinapril (+HCT) Ramipril Spirapril Temocapril Trandolapril Phosphonate-containing: Fosinopril (+HCT) Other/ungrouped: Alacepril

AIIRAs ("-sartan")	Azilsartan Candesartan Eprosartan Fimasartan Irbesartan Losartan (+HCT) Olmesartan (+amlodipine) Tasosartan^§ Telmisartan (+HCT) Valsartan (+HCT, +amlodipine, +sacubitril)

Renin inhibitors ("-kiren")	Aliskiren (+amlodipine, +amlodipine and HCT) Remikiren^§

^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

This article is issued from Wikipedia - version of the 2/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.